AMCP

#AMCP2026 is officially wrapped. The biggest takeaway for non-attendees: this meeting is where evidence, policy, and real-world decision-making collide — and where people build the relationships that help them act on it. #AMCP2026

Today in managed care: The New York Times reports that on Thursday, SCOTUS ruled that mifepristone, “a widely used abortion medication, could continue to be prescribed by telehealth and sent to patients by mail.” nytimes.com/2026/05/14/us/…

Your voice matters on Capitol Hill. Next week at AMCP Legislative Days, managed care pharmacy professionals meet with lawmakers to push for solutions that lower costs and improve patient access to medications. Learn More: hubs.li/Q04gHv5w0 #WeAreAMCP #ManagedCare #Pharmacy #DrugPricing

Your voice matters on Capitol Hill. Next week at AMCP Legislative Days, managed care pharmacy professionals meet with lawmakers to push for solutions that lower costs and improve patient access to medications. Learn More: hubs.li/Q04gG1jl0 #WeAreAMCP #ManagedCare #Pharmacy #DrugPricing

Today in managed care: Healio reports research presented at the European Congress on Obesity found that "once-weekly injectable semaglutide 2.4 mg was linked to reductions in body weight and improvements in multiple cardiometabolic parameters for older adults with obesity." healio.com/news/endocrino…

AMCP is engaging payers and providers to align coverage and reduce gaps in precision medicine adoption. Learn more at hubs.li/Q04dP5xM0 #PrecisionMedicine #WeAreMCPs

Thanks largely to loopholes in the U.S. patent system, Americans aren’t expected to get generic forms of the drug in Novo Nordisk’s Ozempic and Wegovy until at least the end of 2031. nbcnews.com/health/health-…

What if switching cancer meds isn't the answer—just lowering the dose? Ryan Haumschild and oncology pharmacist Timothy Mok (Kaiser Permanente) dig into non-medical switching in CLL/SLL and surface a practice that's wildly underused: dose modification. Timmy walks through real data showing patients on reduced doses live just as long, with fewer side effects and better adherence. They also get into the messy stuff—payer pressure, patient panic when coverage changes overnight, and why "liberty of time" matters when a switch has to happen. Sponsored by AbbVie. Listen now → hubs.li/Q04gvGnQ0 #AMCPUnscripted #cancer #managedcare #pharmacy #switching #CLL, #SLL

Today in managed care: The New York Times reports FDA Commissioner Marty Makary “resigned on Tuesday after weeks of pressure and rumors that” the President “was planning to fire him.” nytimes.com/2026/05/12/us/…

Success Through Community Working in managed care pharmacy and not taking advantage of AMCP? Leverage the community today! Learn more: hubs.li/Q04fgTmt0 #WeAreMCPs #WeAreAMCP #RealMCPVoices #MCPWithAdvantage #LeverageAMCP

Today in managed care: The New York Times reports, "Justice Samuel A. Alito Jr. has paused until at least Thursday a federal appeals court ruling against the" FDA "that would restrict access by mail to mifepristone." nytimes.com/2026/05/11/us/…

Insights on AI At AMCP, we’re looking at ways AI can safely improve medication access, streamline approvals, reduce costs, and enable precise efficient patient‑centered pharmacy. Join the conversation here, hubs.li/Q04fgTH50 #WeAreMCPs #WeAreAMCP #ImprovePatientCare #ThoughtLeadership

Today in managed care: Reuters reported, "US health department officials...explored whether they could ban certain drugs in a widely prescribed class of antidepressants." and that "interest centered on specific treatments within a class known as selective serotonin reuptake inhibitors, or SSRIs." reuters.com/business/healt…

AMCP is working with health care stakeholders to overcome challenges and enhance the integration of Real-World Evidence (RWE) into health care decision-making. Learn more at hubs.li/Q04dNSHZ0 #RWE #WeAreMCPs

Today in managed care: KFF Health News reports "an analysis by 46brooklyn found that close to 1,000 brand drugs went up in price in January 2026. What’s more, 2025 had the highest number of list price increases ever.” kffhealthnews.org/health-care-co…

Today in managed care: Endocrinology Advisor reports, “Glucagon-like peptide-1 (GLP-1) receptor agonist use is associated with a lower risk of developing Parkinson disease, according to study findings.” endocrinologyadvisor.com/news/glp-1-rec…

AMCP is working to solve the metabolic health crisis by advancing guidance, education, and collaboration to support aligned coverage, equitable access, and improved outcomes. Learn more at: hubs.li/Q04dNDJV0 #metabolic-health #GLP-1 #WeAreMCPs

Today in managed care: Reuters reports the Administration "said on Tuesday its ‘Most Favored Nation’ (MFN) drug pricing deal was expected to generate $64.3 billion in federal and state savings in the next 10 years." reuters.com/business/healt…

The voice of managed care is your voice; with all the Resources, Education, Advocacy, Insights, and Thought Leadership to stay on top of a rapidly evolving managed care landscape. Learn more: hubs.li/Q04f7Dgp0 #WeAreMCPs #WeAreAMCP #RealMCPVoices #StayAheadMCP

Research from @IQVIA_global presented at @amcporg 2026 conference highlights the rapid expansion of GLP-1 markets. While there is growing demand, systemic challenges persist. Approximately 28% of patients stop taking obesity treatments within the first year, often due to inconsistent coverage or cost barriers--reinforcing the need for a more stable health infrastructure to support long-term clinical pathways for chronic disease management. More from @MHExecutive: managedhealthcareexecutive.com/view/glp-1-dru…

Today in managed care: The New York Times reports the US Supreme Court on Monday restored nationwide access to mifepristone “in a temporary order that will, for now, allow women to once again obtain the [drug]...by mail.” nytimes.com/2026/05/04/us/…